Shutdown bars FDA officials from attending conferences

10/4/2013 | PharmExec.com

The U.S. government shutdown prevented FDA and NIH officials from attending the Drug Information Association's Clinical Trial Disclosure conference in Maryland, and FDA participants had to leave the Regulatory Affairs Professionals Society meeting in Boston, Jill Wechsler writes. The FDA stopped routine drug manufacturing facility inspections and clinical research locations, as well as accepting new regulatory filings that carry fees, she writes. Possible consequences include delays in carrying out programs and issuing documents, as well as missed review deadlines. Many FDA employees may have to be removed from the agendas of upcoming conferences.

View Full Article in:

PharmExec.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Director of Litigation
Center for Science in the Public Interest
Washington, DC
Health Plan CEO - Oregon
Trillium Community Health Plan
Eugene, OR
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC